Assay vs Purity in Peptides: Reading the Right Number
For dose calculations, use the assay value, also called net peptide content, not the HPLC purity percentage. Purity tells you how clean the chromatographic peak looks; assay tells you how much actual peptide mass sits in that vial. A peptide can carry 98% HPLC purity and still contain only 70% to 90% peptide by weight once you account for counterions and residual moisture, according to research on counterions and peptide content. Before you weigh out anything, run three checks on the Certificate of Analysis:
- Are both method names listed (RP-HPLC for purity, AAA or nitrogen determination for content)?
- Is the actual chromatogram included, not just a summary number?
- Does the COA carry a lot number and name the testing lab?
If content isn’t reported anywhere on the document, treat the vial conservatively or verify it in-house before you calculate a dose.
TL;DR:
- The net peptide content, not HPLC purity, should be used for dose calculations because it reflects the actual peptide mass in the vial.
- HPLC purity indicates chromatographic cleanliness but does not specify the amount of peptide; it can be misleading if used alone.
- Counterions like TFA can comprise 10% to 40% of the vial mass, significantly reducing the peptide actual weight despite high purity figures.
- Confirming the peptide’s identity via LC-MS and verifying content through AAA or nitrogen determination are essential steps before critical experiments.
- Lot-specific third-party COAs are critical for consistency, and researchers need proper documentation to ensure accurate dosing and reproducibility.
Assay vs Purity Peptides: What Each Number Actually Measures
Assay, or net peptide content, is an absolute mass fraction. It tells you what percentage of the vial’s total weight is actual peptide, as opposed to salts, counterions, and water clinging to the lyophilized powder. Labs typically establish this figure through amino acid analysis (AAA) or nitrogen determination, both of which measure the chemical building blocks of the peptide directly rather than inferring them from a chromatogram, as outlined in guidance on net peptide content versus purity. Quantitative NMR (qNMR) is increasingly used as a third method for absolute quantitation, since it doesn’t rely on a reference standard the way AAA sometimes does.
Purity, by contrast, is a relative measurement. Reverse-phase HPLC (RP-HPLC) separates a sample’s components and reports the percentage of total UV-integrated peak area that belongs to the main peptide peak, most commonly detected at 214 nm, according to Compound Review’s explanation of peptide purity standards. That number says nothing about the non-peptide mass in the vial. It also depends heavily on how the analyst sets integration parameters. Two labs running the same sample can report slightly different purity figures if their peak-integration thresholds differ.
Identity confirmation via LC-MS is the third axis. It answers a different question entirely: is this actually the peptide it claims to be, and not a truncated or deamidated variant with a similar retention time?
A quick reference on what each method answers:
- Assay/net peptide content — how much peptide mass is in this vial?
- HPLC purity — how clean does the chromatographic peak look?
- LC-MS identity — is this the correct molecule?
Statistic to remember: Residual TFA content commonly runs 10% to 40% by mass in peptides with multiple basic residues, meaning a 1 mg vial may contain substantially less than 1 mg of actual peptide once the counterion salt is accounted for.
How Labs Measure Purity and Assay in Practice
Every method on a COA is answering a narrower question than researchers often assume, and knowing which one applies to which claim keeps you from misreading a report.
RP-HPLC remains the workhorse for purity assessment. A well-documented run should specify the column type (commonly C18), the solvent gradient, the detection wavelength (214 nm is standard for peptide bonds), and the total run time. These details matter because a shallow gradient can artificially inflate purity by failing to resolve closely related impurities, while a wavelength choice can under or overrepresent certain side products. A COA that omits gradient and column information is giving you a number with no way to judge how rigorously it was earned.
LC-MS confirms identity by matching observed mass to expected mass, often cross-checking the isotopic envelope for confidence. It’s excellent at catching truncated sequences or unexpected modifications, but it has real limits: it can’t tell you how much of the sample is peptide by weight, and closely related isomers sometimes produce nearly identical mass spectra.
Amino acid analysis and nitrogen determination are the standard routes to net peptide content, hydrolyzing the peptide into its constituent amino acids and quantifying them against reference standards. qNMR offers an alternate absolute quantitation method that doesn’t require hydrolysis, which makes it useful for cross-validating AAA results.
Karl Fischer titration measures residual water content, while ion chromatography or fluoride-selective methods quantify TFA and other counterions. Both feed directly into the assay calculation.
| Method | Question answered | What it can’t tell you |
|---|---|---|
| RP-HPLC (214 nm) | How clean is the chromatographic peak? | Absolute peptide mass |
| LC-MS | Is this the correct molecule? | Purity percentage or mass fraction |
| AAA / nitrogen determination | How much peptide mass is present? | Chromatographic impurity profile |
| qNMR | Absolute peptide quantity (cross-check) | Sequence identity |
| Karl Fischer / ion chromatography | Water and counterion content | Peptide identity or purity |
For any quantitative research application, the USP’s guidance on reference standards recommends combining multi-orthogonal identification (NMR, peptide mapping, HPLC, AAA) with mass-balance accounting rather than trusting any single method in isolation.
Reading a COA: A Worked Dosing Calculation
Before you calculate anything, scan the COA for five specific items: the purity method and its parameters, the content/assay method used, whether a chromatogram image is included, the reported counterion percentage, and the residual water percentage. Missing any of these should raise a flag, not just an eyebrow.
Here’s how the math actually works when the numbers are complete. Say a COA reports 98% HPLC purity and 75% net peptide content for a vial labeled 1 mg.
- Start with the labeled vial weight: 1 mg total lyophilized material.
- Apply the net peptide content, not the HPLC purity, to find actual peptide mass: 1 mg × 0.75 = 0.75 mg of actual peptide.
- The remaining 0.25 mg is counterion (commonly TFA or acetate), residual moisture, or trace synthesis byproducts.
- The 98% HPLC purity figure tells you that of the peptide-related material detected in that chromatographic run, 98% belongs to the main peak. It says nothing about the 0.25 mg of non-peptide mass.
Pro Tip: When a COA reports only HPLC purity with no content figure, treat the vial as if net content could be meaningfully lower than the purity number suggests. Request AAA data from the supplier, or run an in-house calibration against a known reference before using the material in any quantitative assay.
A partner resource worth bookmarking is this guide to reading a peptide Certificate of Analysis, which walks through additional COA components lab-by-lab.
Why the Assay-Purity Gap Matters for Reproducible Research
Confusing purity with content doesn’t just produce a rounding error. It skews the science. Two labs running the “same” peptide from different lots, without knowing the actual net content differed, can report inconsistent dose-response curves and never figure out why.
Minimum quality control for any quantitative work should include three things:
- Net peptide content for every calculation involving dose or concentration, not HPLC purity.
- MS identity confirmation before the material enters a critical experiment.
- An in-house RP-HPLC check reserved for each new lot used in reproducibility-sensitive assays, even when a supplier COA is on file.
Pro Tip: Log the lot number alongside every experimental result, not just the product name. When a result doesn’t replicate six months later, the lot number is usually the fastest way to trace whether the peptide itself changed. Our lab best practices guide covers on-receipt verification steps in more detail.
How Peppy&Me Approaches COA Transparency
Researchers shouldn’t have to guess which number on a COA to trust. Peppy&Me tests every batch through third-party laboratories for purity, mass accuracy, endotoxins, sterility, and heavy metal, with results tied to a specific lot number traceable from manufacturer to warehouse.
A COA is only as useful as its documentation. A purity figure without method details, a chromatogram, or a lot number is a claim, not evidence. That’s the standard we hold every batch to before it reaches a researcher’s bench.
Beyond testing, Peppy&Me builds tools around the numbers themselves:
- A dose calculator that helps convert reported content figures into actual preparation volumes.
- A peptide glossary explaining assay, purity, identity, and related terminology in plain language.
- A secure membership portal with order tracking, same-day shipping for orders placed before 2 PM, and real-time support for researchers who have COA-specific questions.
Assay, Purity, and Potency: Untangling the Terminology
These three terms get used interchangeably in casual conversation, and that’s exactly where confusion starts. Purity describes chromatographic cleanliness, the percentage of detected material that matches the main peptide peak. Assay, in the analytical chemistry sense used on a COA, refers to the quantitative determination of how much of a target substance is present, which is why “assay value” and “net peptide content” are often used as synonyms in peptide documentation.
Potency is a related but distinct concept, and it’s the one most often confused with both. Potency measures biological or functional activity, how effectively a peptide performs in a given assay system, expressed relative to a reference standard. A peptide can have excellent purity and accurate content labeling yet still show reduced potency if it has undergone partial degradation that doesn’t show up clearly on a standard HPLC trace or if its three-dimensional folding has been compromised during storage.
The distinction matters because Torontech’s comparison of assay and purity in HPLC frames it well: assay answers “how much of the target is present,” while purity answers “what else is present.” Potency asks a third question entirely: “does it still work as intended?” A batch can pass its assay specification and still fail a purity limit for a single trace impurity above 0.10%, triggering a full batch investigation even though the headline potency number looked fine.
For research-use-only material, there’s no legally mandated numerical threshold tying these three terms together, which is precisely why documentation quality, not marketing language, is what separates a transparent supplier from a vague one.
What Counts as an Acceptable Assay or Purity Value
There’s no single legal purity threshold that applies across all research peptides, since RUO material falls outside FDA-regulated commercial drug specifications. That said, the peptide research field has converged around some practical benchmarks that most quality-focused suppliers use as internal targets.
For HPLC purity, a high percentage is generally considered a strong specification for standard research peptides, with more complex or longer sequences sometimes accepted at lower purity because synthesis difficulty increases with chain length. Lower purity usually signals either an early-stage synthesis batch or lower purification effort.
Net peptide content specifications vary due to differences in counterion forms. A TFA salt might show lower net content on a COA than an acetate-exchanged version of the same peptide because of the difference in non-peptide mass contributed by these counterions. Both numbers reflect valid measurements of the same peptide in different salt forms.
The pharmacopeial approach, as described in USP’s reference standard guidance, treats these as a two-step value assignment: establish bulk purity first, then assay the vialed material separately, since freeze-drying and vialing can introduce additional moisture variance. A COA that reports only one figure, with no separate accounting for bulk versus vial-specific values, is giving you an incomplete picture.
Troubleshooting When Assay and Purity Don’t Line Up
A common point of confusion happens when a peptide shows excellent HPLC purity, say 98%, alongside a net peptide content that seems surprisingly low, like 65%. Researchers sometimes assume this signals an error or a contaminated batch. In most cases, it doesn’t. It signals a peptide with a high counterion load, often TFA, combined with residual moisture from lyophilization.
The fix isn’t to distrust the COA. It’s to check whether both figures were actually reported using appropriate methods. A few real-world discrepancy patterns worth recognizing:
High purity, unreported content. If a COA shows only HPLC purity with no assay figure at all, that’s not a discrepancy so much as an information gap. Request the AAA or nitrogen determination data directly, or run an in-house calibration before using the material for dosing.
Content appears higher than expected for the salt form. If a TFA-salt peptide reports net content above 90%, that’s worth a second look. It may indicate the supplier performed partial counterion exchange, or it may reflect a measurement inconsistency between labs. Cross-checking against a second lot’s COA can clarify which.
Purity drops between lots of the “same” peptide. This usually traces back to synthesis batch variation rather than a testing error. Longer or more hydrophobic sequences are more prone to lot-to-lot purity drift, which is exactly why lot-specific COAs, rather than a single generic specification sheet for a product line, matter for reproducibility.
When in doubt, Peppy&Me’s peptide sourcing guide walks through what documentation to request when a COA raises more questions than it answers.
Why Documentation Beats a Percentage on Its Own
We keep coming back to lot-level COAs and third-party verification because a percentage without a method behind it is just a marketing claim in disguise. Our practical recommendation is simple: run a quick on-receipt check, confirm the numbers, and document the lot before you start a quantitative assay. RUO labeling was never meant to guarantee quality on its own. Documentation is what actually does that job.
— Peppy&Me
Where to Find Lab-Verified Peptides With Real COA Documentation
Reading a COA correctly only helps if the underlying data is actually there to read. Peppy&Me built its catalog around that principle: every product ships with a lot-specific Certificate of Analysis covering purity, mass accuracy, endotoxins, sterility, and heavy metals, verified through third-party labs rather than self-reported figures.
If you’re comparing options for an upcoming experiment, the GLOW Blend Peptide and KLOW Blend Peptide product pages both list lot-specific testing documentation you can review before ordering. Researchers working with signaling peptides can find the same standard applied on the Kisspeptin, VIP, Sermorelin, and BPC-157 listings. Once you’ve picked a product, the built-in dose calculator converts reported content figures into actual preparation volumes, and same-day shipping on orders placed before 2 PM means you’re not waiting around to start a time-sensitive protocol. If a COA detail isn’t clear, real-time support can pull the specific lot documentation while you’re still deciding.
Key Takeaways
Net peptide content, not HPLC purity, is the correct figure for calculating actual peptide dose, while HPLC purity indicates chromatographic cleanliness and impurity risk.
| Point | Details |
|---|---|
| Use assay for dosing | Net peptide content, from AAA or nitrogen determination, gives the real mass fraction for calculations. |
| Use purity for cleanliness | HPLC area percent at 214 nm shows how clean the chromatographic peak looks, not absolute mass. |
| Counterions drive the gap | TFA and other counterions can account for 10% to 40% of vial mass, per PMC research. |
| Confirm identity separately | LC-MS answers whether the molecule is correct, a question neither purity nor assay addresses alone. |
| Choose lot-verified sources | Peppy&Me provides third-party COAs with purity, content, and safety testing tied to specific lots. |
Sources
- Peptide purity standards: HPLC, mass spec, and what >98% really means | Compound Review
- Net Peptide Content vs Purity: Reading Both on a CoA | PeptideTrust
- Reference standards to support quality of synthetic peptide therapeutics | USP
FAQ
Are assay and purity the same thing?
No. Assay (net peptide content) measures the absolute mass fraction of peptide in a sample, while purity measures the percentage of chromatographic peak area belonging to the main peptide peak. A sample can score high on one and moderate on the other.
Are purity peptides reliable for research?
Reliability depends on documentation, not the purity number alone. A peptide backed by a lot-specific COA showing method details, a chromatogram, and third-party testing, like the products Peppy&Me lists, is far more dependable than an unlabeled high percentage with no supporting data.
What is the most accurate lab test for peptides?
No single test covers everything. RP-HPLC assesses chromatographic purity, LC-MS confirms molecular identity, and amino acid analysis or qNMR establishes absolute peptide content. Quantitative research typically requires combining at least two of these methods.
Is 98% purity good for a peptide?
The actual peptide mass in the vial depends on net content, which can run meaningfully lower once counterions and moisture are factored in.